Company intelligence / Profile preview

AskBio

Research Triangle Park, North Carolina, USAaskbio.com ↗
Ownership
Private
Employees
~900
Development stage
Other
01

Overview

AskBio has a rapidly expanding pipeline of investigational AAV-based gene therapies targeting rare genetic diseases. Several proprietary vectors have entered clinical testing. The company leverages its platform to develop treatments aimed at erasing genetic diseases with ongoing clinical programs in neuromuscular and CNS indications. It is advancing multiple candidates through early to mid-stage clinical development[1][2][3][4][5][6].

Therapeutic areas
PulmonologyRare DiseasesNeurologyCardiovascular
Modalities
AAV (Adeno-associated virus) gene therapy vectorsProprietary cell line manufacturing process (Pro10™)Synthetic promoters and DNA technologyExtensive capsid library for gene delivery
Industry
Biotech
02

Drug pipeline

16 assets

NAN-101

2

15 more assets in the full pipeline.

03

Partnerships

Collaborations/licensing agreements with Pfizer (Duchenne muscular dystrophy)Takeda (Hemophilia via Chatham Therapeutics)Novartis/AveXis among others who license or use their technologies[3][4].

Beyond the preview

Go deeper on AskBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AskBio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call